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Abstract
Measles, a highly infectious vaccine-preventable viral disease, is potentially fatal. Historically, measles case-fatality
ratios (CFRs) have been reported to vary from 0.1% in the developed world to as high as 30% in emergency set-
tings. Estimates of the global burden of mortality from measles, critical to prioritizing measles vaccination among
other health interventions, are highly sensitive to the CFR estimates used in modeling; however, due to the lack of
reliable, up-to-date data, considerable debate exists as to what CFR estimates are appropriate to use. To determine
current measles CFRs in high-burden settings without vital registration we have conducted six retrospective
measles mortality studies in such settings. This paper examines the methodological challenges of this work and
our solutions to these challenges, including the integration of lessons from retrospective all-cause mortality studies
into CFR studies, approaches to laboratory confirmation of outbreaks, and means of obtaining a representative
sample of case-patients. Our experiences are relevant to those conducting retrospective CFR studies for measles or
other diseases, and to those interested in all-cause mortality studies.
Introduction
Measles, a highly infectious vaccine-preventable viral
disease, is characterized by clustering of cases that occur
during cyclical epidemics [1]. In many parts of the
world, measles is also a seasonal disease with fewer
cases found during the non-measles season [2]. Clini-
cally, the infection is expressed as a maculopapular rash
accompanied by fever and at least one of the three “c’s":
cough, coryza and conjunctivitis; virtually all cases of
measles are clinically expressed [3,4]. Measles is a
potentially fatal disease [1]. The World Health Organi-
zation (WHO) defines a measles-associated death as one
occurring within 30 days of rash onset, not obviously
due to another cause such as trauma [5].
Historically, measles case fatality ratios (CFRs) have
been reported to vary from 0.1% [1] in the developed
world to as high as 30% among refugee populations
[6,7]. Current estimates of CFRs used by WHO in
endemic countries range between 0.05% - 6% [8-10].
Factors thought to affect CFR include age [11], inten-
sity of exposure to measles virus (for which household
crowding may be seen as a surrogate) [12], measles
vaccination status [13], nutritional status [14],
immunodeficiency [15] and access to appropriate case
management [16]. Studies conducted in the late 1980 s
demonstrated that supplementation of measles case-
patients with vitamin A could decrease measles mortal-
ity by as much as 64% [17,18] leading to recommenda-
tions by WHO and United Nations Children’sF u n d
(UNICEF) in 1987 to treat all measles case-patients
with vitamin A in areas where measles CFRs were
greater than 1% [19]. These recommendations, in con-
junction with the rollout of Integrated Management of
Childhood Illness (IMCI) guidelines in the mid 1990 s
[20] which target pneumonia and diarrhea, might be
anticipated to have decreased measles CFRs since the
1990 s. However, few data exist on the extent to which
these interventions are used in health facilities, particu-
larly in countries that are highly endemic for measles.
Anecdotal evidence from outbreak investigations in
Niger, Sudan and South Africa indicate that these
interventions are underused [21-24].
Further decrease in CFRs in the past decade may have
occurred due to the renewed political will and creation
of the Measles Initiative in 2001. WHO and UNICEF
developed a comprehensive strategy for sustainable
measles mortality reduction with the goal of a 90%
reduction in global measles deaths (compared with 2000
levels) by 2010.
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tine immunization, providing all children with a second
dose of measles vaccine delivered either through peri-
odic SIAs or routine services, improved measles case
management and careful measles surveillance. This
strategy has contributed to reducing the overall burden
of measles and has potentially led to decreased CFR
linked to earlier detection and improved case
management.
Recently the global burden of mortality from measles,
critical in prioritizing measles vaccination relative to
other health interventions, has been an area of much
discussion. A published point estimate from a 2003 ana-
lysis of childhood mortality using a proportional mortal-
ity model [25,26] differed by hundreds of thousands of
deaths from the WHO point estimate for the same per-
iod using a static natural history model [27]. A major
factor contributing to this discrepancy has been dis-
agreement over which CFRs are appropriate to use in
models seeking to estimate global burden of measles
deaths, in particular what CFRs are appropriate to use
in countries that are highly endemic for measles. In
these settings, disease reporting, death surveillance and
vital registration tend to be incomplete or non-existent,
requiring the collection of primary data to determine
disease-specific CFRs.
The recent controversy surrounding measles CFRs in
the developing world and the paucity of up-to-date data
on this topic have led us to conduct six published stu-
dies to determine measles CFR in five countries (Niger
[21,24], Sudan [22], Nepal [28], Chad [24] and Nigeria
[24], Table 1). Although a recent publication reviewed
existing literature to better estimate probable CFRs by
geographic region [10], there is little published guidance
on the conduct of field studies to determine measles
CFR. This paper aims to fill this gap by summarizing
both the challenges that are inherent in such studies,
and the approach that we advocate given these chal-
lenges. Improving the rigor of future studies in this
t o p i ca r e aw i l lc o n t r i b u t et om o r ea c c u r a t eb u r d e no f
mortality estimates.
Analysis
We analyzed our experience in conducting measles CFR
studies and drew on the published literature to review
critical considerations in designing CFR studies. Below,
we first review the key components of a CFR study. Sec-
ond, we summarize and provide recommendations for
the conduct of future studies.
Study type
Prospective disease and death surveillance can be used
to determine disease-specific CFRs. However, because
highly effective interventions now exist to prevent cases
and deaths, it is ethically unacceptable to follow measles
outbreaks without offering vaccination to affected com-
munities and optimal case management, including vita-
min A supplementation, to case-patients. Further,
because this standard of care may not be routinely avail-
able, the CFR from such a prospective study may not
reflect the true background rate. As a result, the true
risk of death may best be studied retrospectively by con-
ducting a cross-sectional survey to determine the num-
ber of measles cases that occurred in a defined area
during a pre-determined period, and the number of
associated deaths.
In conducting a retrospective study of this type, a cri-
tical issue is defining the recall period. Guides for the
conduct of retrospective mortality surveys and their
strengths and weakness have been described in the lit-
erature [29,20]. The recall period must be long enough
such that sufficient cases and deaths occur for a precise
CFR calculation, but on the other hand, the longer the
recall period, the greater the likelihood of recall bias.
Because measles is a disease found primarily in epi-
demics, identifying an adequate number of measles
cases to determine measles CFR with some precision
generally requires selecting the recall period to fall
within the epidemic. Particularly in settings where
m e a s l e si sh i g h l ys e a s o n a l ,this may restrict the period
of interest to only several months. The survey must
then be conducted toward the end of or very shortly
after the epidemic season. Furthermore, determining
measles CFRs retrospectively requires identification of
all cases of measles within a household, as well as all
deaths occurring in measles case-patients within 30 days
of rash-onset. (The definition of a measles case is dis-
cussed in the forthcoming section). These requirements
presuppose detailed recall, but permit focus on a short
period (e.g., 3-6 months) prior to the survey.
Ascertainment of cases and deaths
To accurately determine CFR, both the number of
measles cases and associated deaths occurring during
the recall period are needed. Literature on all-cause
mortality shows that asking in aggregate about deaths
occurring in the past 12-24 months results in 30%-40%
under-reporting of deaths [30,31]. In addition, differen-
tial reporting by both age and gender [32] occurs, with
the deaths most frequently omitted variously reported as
those among young children [33] and those among chil-
dren aged 5-15 years [30]. These findings on omission
of childhood deaths have led to recommendations in the
literature that mothers or other household women serve
as respondents [34]. An additional difficulty concerns
ascertaining the exact age of household members. Births
and deaths are not routinely recorded and age is almost
always imprecise. Further, rather than reporting deaths
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Page 3 of 8in aggregate, household enumeration should be con-
ducted in order to permit every individual present in
the household at the beginning of the recall period, or
who joined the household during the recall period, to be
accounted for [35,36]. We were unable to find literature
on the accuracy of retrospective determination of
measles cases. However, one might assume that steps
recommended to minimize omission of deaths might
also minimize the omission of cases.
A further challenge in conducting retrospective studies
of measles is ensuring that the illness studied is indeed
measles. Misclassification of rash-fever illness will result
in inaccurate CFR estimates. Ensuring that the disease is
measles is straightforward if cases have been laboratory
confirmed. However, when this is not the case, it is
necessary to rely upon history.
Laboratory confirmation of measles cases
Although measles has distinctive clinical features, it can
be mistaken for illness due to other causes, most fre-
quently rubella. Thus, measles should be confirmed by
collecting serum for testing between days 3 and 28 after
rash onset [37]. The implementation of a global measles
mortality strategy has led to improved surveillance for
measles and the development of a global measles labora-
tory network [38,39], making laboratory confirmation of
measles cases more widely available. However, develop-
ment of laboratory capacity has been focused in coun-
tries that have initiated accelerated measles control, and,
even in these settings, laboratories rapidly become over-
whelmed during outbreaks [40]. As a result, current
WHO recommendations are to limit laboratory confir-
mation to 5 - 10 specimens per outbreak, although the
geographic area implicated (e.g., community, district) is
undefined [41]. This recommendation takes into account
t h ef a c tt h a tt h ep o s i t i v ep r e d i c t i v ev a l u eo ft h ec l i n i c a l
case definition for measles increases greatly in the con-
text of an outbreak [42].
The usual WHO laboratory protocol specifies testing
for rubella if serum from a suspected measles case tests
negative for measles. This has led to the recognition
that some outbreaks thought clinically to be due to
measles were in fact attributable to rubella, and has also
led to confirmation of measles and rubella outbreaks
occurring simultaneously in the same communities. In
these circumstances, it is difficult to determine by his-
tory alone which rash-fever cases were due to measles
and which to rubella, thus rendering accurate determi-
nation of disease-specific CFRs unfeasible.
In summary, in most measles-endemic settings it is
rare that case-patients have laboratory confirmation of
measles infection, although it is usually possible to test
whether the rash-fever illness circulating is measles.
Verifying measles infection in the actual case-patients
that we wish to study - i.e., those that have survived 30
days after rash onset and those that have died - remains
virtually impossible, as these are patients in whom it is
too late to perform confirmatory laboratory testing.
Use of verbal autopsy questions
As most measles cases in endemic settings are never
subjected to laboratory testing, in retrospective studies
history must be used to identify cases. Although a vast
literature on verbal autopsies exists, these studies have
focused primarily on use and validation of verbal
autopsy methodology [43,44]. Verbal autopsy methodol-
ogy has been extensively used in retrospective mortality
studies addressing measles. Two approaches have been
used: a clinical algorithm and the local term for measles.
The algorithm using age ≥ 120 days, fever ≥ 3 days, and
rash to identify measles cases has shown sensitivity
ranging from 67% - 98%, and specificity ranging from
85% - 99% [45-47]. WHO recommends the use of either
the algorithm or the local term [48]. In studies that
compared this algorithm to the use of the local term for
measles, the local term was more sensitive and more
specific [49].
Obtaining a representative sample of measles case-
patients
In order to obtain a precise estimate of CFR, it is impor-
tant to include an adequate number of measles cases in
the sample. This number will depend upon the precision
desired, as well as the pre-study estimate of CFR
(Table 2). Estimates of probable CFRs for different
regions have been published previously and can be used
as a guide for determining sample size [10]. The level of
precision desired will depend on the ultimate use of the
CFR estimate, but should be as precise as possible. Ide-
ally, the sample should be selected from a sampling
frame of all case-patients resident in the geographic area
Table 2 Number of measles case-patients required to
retrospectively estimate measles CFR based on expected
CFR and desired precision
95% Confidence Intervals
Expected CFR ± 0.5% ± 1% ± 2% ± 3% ± 4% ± 5%
1% 1519
2% 3003 752
3% 4452 1117 279
4% 5866 1473 369 164
5% 7246 1821 456 203 114
10% 13641 3445 864 384 216 138
15% 19215 4874 1223 544 306 196
20% 23995 6109 1534 682 384 246
Note: Sample sizes will need to be adjusted based on design effect and
response rate
Cairns et al. Emerging Themes in Epidemiology 2010, 7:4
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Page 4 of 8of interest with rash onset during the period of interest.
However, in the absence of a highly sensitive and speci-
fic surveillance system, such a sampling frame does not
exist. Because measles tends to be highly clustered in
both place and time, a sample drawn from the general
population may result in a very large number of indivi-
duals being surveyed before an adequate number of
measles case-patients is identified.
Risk factors
In addition to estimating CFR, one would like to assess
risk factors for increased or decreased CFR among the
population studied.
Nutritional status
Poor nutritional status has been thought to be asso-
ciated with increased measles CFR, and so one would
like to know the nutritional status of measles case-
patients at the time of rash onset. However, when con-
ducting a retrospective study in a remote location, this
information is rarely available. Instead, some have con-
sidered using the nutritional status of family members
or of the general community at the time of the survey.
However, this approach assumes that nutritional status
of those still alive is representative of the nutritional sta-
tus at disease onset of those who died - which appears
unlikely. In some very poor rural communities depen-
dent on subsistence agriculture, there is seasonal fluc-
tuation in the prevalence of wasting. As a result, the
community nutritional status during the CFR investiga-
tion may not reflect the community nutritional status a
few months earlier during the measles outbreak. Logisti-
cally, determining current nutritional status adds com-
plexity to field work as enumerators must be trained in
anthropometry. If the nutritional status of the commu-
nity as a whole is to be considered, a population-based
sample must be selected for study.
Vaccination status
Children who received at least one dose of measles-con-
taining vaccine have a lower CFR and reduced complica-
tions. Milder measles disease is also associated with a
lower CFR in vaccinated children. In some contexts,
proof of vaccination can be verified retrospectively from
vaccination cards provided through routine vaccination
systems or punctual mass vaccination interventions. In
this case, the case-patients’ vaccination status can be
recorded. However, in many instances, card verification
is not possible and history must be relied upon. This
can be achieved by asking the mother if the child was
vaccinated in the upper left arm for measles to avoid
confusion with other antigens, but the possibility of
response bias is always present. However, previous stu-
dies in areas of high measles incidence have shown par-
ental recall to be highly reliable with a predictive value
of approximately 95% [50].
Receipt of vitamin A during measles illness
Receipt of vitamin A during measles illness has been
shown to result in a marked reduction in measles mor-
tality. One would therefore also like to know if measles
case-patients received vitamin A while ill and, if so,
how many doses were received. Since vitamin A is
generally given through health services, it may be pos-
sible to determine whether the patient received supple-
mentation through record review. Alternatively, study
respondents may be shown a vitamin A capsule and
asked whether the case-patient received similar cap-
sules. However, data on vitamin A supplementation
during measles illness only support giving two age-
appropriate doses of vitamin A separated by 24 hours,
as a single dose has not been shown to reduce measles
mortality [51]. Record documentation is rarely ade-
quate to determine whether two doses were adminis-
tered. Furthermore, in countries conducting frequent
polio National Immunization Days (NIDs), respondents
may confuse the drops of medication from a vitamin A
capsule with the drops of oral polio vaccine. In sum-
mary, it is quite challenging to obtain accurate infor-
mation on the receipt of vitamin A and, if received,
the number of doses.
Case management
Although quality of case management may be an impor-
tant risk factor for death, adequate evaluation is com-
plex. The major clinical complications of measles
leading to death are pneumonia and diarrhea. Evaluation
of case management for these includes issues such as
appropriate determination of pneumonia and diarrhea,
and appropriate choice and dosing of antibiotics (for
pneumonia) or appropriate use of oral rehydration solu-
tion (for diarrhea).
Our Approach to Estimating Measles CFR
Taking into account the relevant literature, field experi-
ence, and the many challenges mentioned above, we
have gradually developed a standardized approach to
conducting measles CFR studies.
Study type
We conducted only retrospective studies for the reasons
mentioned previously. In order to best identify all cases
and deaths, we used a household census approach, con-
ducting a complete household census of those resident
in the household at the beginning of the recall period
and using this list to identify those who developed rash
illness and died within thirty days of rash-onset. When-
ever possible, we limited respondents to mothers or, if
they were unavailable, other women within the house-
hold. Furthermore, we have limited the recall period to
3-12 months prior to the date of the survey, with the
start and end of the period corresponding to a major
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end of the epidemic season or shortly after.
In one study [21] we had the survey supervisors revisit
households with reported measles deaths to confirm the
numbers of measles cases and deaths. In addition, one
of the primary investigators conducted follow-up house-
hold visits to ascertain whether the number of measles
cases and deaths detected at the first visit matched
those at the second visit, prioritizing households in
which the questionnaire responses were unclear or
incomplete. These follow-up visits comprised approxi-
mately 10% of households.
Despite increasing the likelihood that measles cases
and deaths will be accurately detected, this approach
has its own difficulties: household enumeration is time-
consuming, and respondents may be suspicious of the
motives for enumeration. This is particularly challenging
when conducting studies in refugee or displaced popula-
tions, in which respondents may infer that benefits are
tied to their response.
Ascertainment of cases and deaths
To maximize the likelihood that the rash-fever illness
we are studying is truly measles, we have opted to con-
firm virologically cases in the same community if the
outbreak is still ongoing or, if necessary, in a neighbor-
ing community to which the community being studied
has epidemiologic links. At times, we have also chosen
to restrict the communities that we consider for study
to those that have had laboratory confirmation of cir-
culating measles [21,22,28]. We have also encountered
co-circulating rubella and measles epidemics [28]. In
these situations, because of the difficulty in differen-
tiating measles and rubella on clinical grounds, a retro-
spective study to determine measles CFR may not be
feasible.
We initially asked about measles infection using ques-
tions extracted from a standardized verbal autopsy ques-
tionnaire. However, when we used the algorithm
[42-44], we doubted our results because they suggested
isolated cases of measles in a poorly vaccinated popula-
tion, a finding inconsistent with the epidemiology of the
disease. We have since chosen to ask about measles
infection by using the local term for the disease and
then verifying that cases thus identified met the stan-
dard clinical case definition for measles, i.e., fever, rash
and at least one of the following: cough, coryza and con-
junctivitis, in case the term for measles in the local lan-
guage covers other rash fever illnesses. We recommend
this latter approach.
Obtaining a representative sample
One of the greatest challenges has been identifying a
method to select a representative sample of cases.
Ultimately, we have chosen to select randomly commu-
nities (or other administrative units) from which several
measles cases have been reported, and to conduct com-
prehensive, active, house-to-house case-searches within
these communities. With this approach, all case-patients
in communities eligible for study have an equal prob-
ability of selection, and findings, including the CFR, can
be generalized to the population of case-patients in the
communities studied. A confidence interval that
accounts for clustering can be calculated. This approach
may be criticized for failing to include sporadic cases
reported to be measles. As indicated earlier, clustering
of cases may lead to increased CFR through increased
intensity of viral exposure; focusing solely on clustered
cases could theoretically lead to an overestimate of true
CFR. However, this is unlikely to have a major influence,
because the vast majority of cases occur in outbreak set-
tings and so even if sporadic cases were in fact true
measles cases, they contribute relatively little to the total
burden of disease. Furthermore, sporadic cases reported
to be measles and meeting clinical criteria are far less
likely to be true measles cases than clinically or labora-
tory-confirmed measles cases in laboratory-confirmed
outbreak settings, because the positive predictive value
of a case definition is much lower when the prevalence
of measles is low [52].
Risk factors
We have generally felt that the logistical difficulties of
conducting a community-wide nutritional survey out-
weighed the potential benefits of doing so. We have
chosen to rely instead upon data from the most recent
Multiple Indicator Cluster Survey [53] or Demographic
and Health Survey [54] to give an indication of probable
community nutritional status, while understanding that
these data may be neither geographically nor temporally
specific to the outbreak under investigation. These sur-
veys are internationally recognized, use standardized
methodologies, permit cross-country comparisons, and
frequently provide the only information available on
country-level nutritional status. If there is no compelling
reason to suspect rapid change in nutritional status, esti-
mates from past surveys may give a rough idea of the
importance of malnutrition in contributing to elevated
CFRs.
We have tried to assess receipt of vitamin A by show-
ing respondents a vitamin A capsule and asking whether
the case-patient received similar medication. Although
we have also asked about number of doses received, we
have questioned respondents’ ability to recall such
detail, particularly several months after the fact. In one
instance, receipt of vitamin A did not show any impact
on measles mortality; leading us to question the reliabil-
ity of the responses we received [21].
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Because of the complexity and additional length of
including evaluation of measles case management in our
surveys, and because our focus was primarily on deter-
mining CFRs rather than evaluating risk factors for
death, we chose not to evaluate measles case manage-
ment in our surveys.
Other considerations
We ensured strong supervision of survey workers with a
supervisor responsible for no more than two or three
teams. Conducting complete enumeration of households
as well as travelling to randomly-selected but distant
locations to conduct studies may add to financial costs.
However, we consider these approaches to be critical to
the rigor of the studies. Studies using convenience sam-
pling or only considering hospitalized cases may be less
costly to conduct, but could lead to biased CFR
estimates.
Conclusion
In conclusion, despite the importance of measuring
current measles CFRs in measles-endemic settings for
prioritizing measles vaccination relative to other health
interventions, the ethical imperative to ensure optimal
measles case management limits the generalizability of
results from prospective studies. Retrospective studies
are in turn limited by recall bias, difficulty ensuring
that rash and fever cases are truly attributable to
measles, difficulty in assessing important risk factors
for increased CFR, and challenges in obtaining a repre-
sentative sample of measles case-patients. Despite
these constraints, we believe that accurate measles
CFRs can be obtained from meticulously conducted
retrospective studies as we have outlined that take into
account the unique characteristics of the disease. Table
3 provides summary guidance for good conduct of ret-
rospective measles CFR studies. Guidelines for conduct
of retrospective mortality surveys have been published
previously [30,35] and well as guidelines to aid in
interpretation [55]. Using these guidelines as a basis, in
addition to those presented in Table 3, will help to
improve the conduct of retrospective measles CFR
studies.
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